Clinical trial · Interventional
Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy
A Brief Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy: A Pilot Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial tests how well an online mindfulness-based intervention (MBI) works to decrease anxiety in patients before a first-time screening colonoscopy. Elevated pre-procedural anxiety can affect patient outcomes including bowel preparation adherence and quality, the amount of sedation required, procedure time, patient satisfaction, cancellation or no-shows, and intention for future cancer screening. Mindfulness is a form of meditation that focuses on staying within the present moment to reduce anxiety. Previous research supports mindfulness practice among cancer survivors to decrease anxiety, fear of cancer re-occurrence, and to improve quality of life. Online MBIs have the potential to include targeted meditations and educational information designed to promote behavior change. This study may help researchers learn whether a mindfulness intervention works to decrease anxiety in patients before a first-time screening colonoscopy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Carcinoma | Colorectal Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Practice | Other | — | UNRESOLVED |
| Medical Chart Review | Other | — | UNRESOLVED |
| Online Mindfulness Meditation | Behavioral | — | UNRESOLVED |
| Survey Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group I (usual care)
- description
- Patients receive usual care prior to their scheduled screening colonoscopy.
- interventionNames
- Other: Best Practice
- Other: Medical Chart Review
- Other: Survey Administration
- type
- EXPERIMENTAL
- label
- Group II (online mindfulness intervention)
- description
- Patients receive an online mindfulness intervention including infographics and 5-minute meditations QD for 5 days prior to their scheduled screening colonoscopy.
- interventionNames
- Other: Medical Chart Review
- Behavioral: Online Mindfulness Meditation
- Other: Survey Administration
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 45 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients must be ages 45-75 * Patients must be at average risk for colorectal cancer (CRC) * Patients must have scheduled their first-time screening colonoscopy as an outpatient at Ohio State University (OSU) at least 14 days in advance * Patients must be able to speak and read English * Patients must have daily access to a working telephone, email address, and internet connection * Patients must provide consent Exclusion Criteria: * Previous colonoscopy * Colonoscopy for diagnostic purposes * Auditory or visual impairment that prevents internet use * Previous cancer diagnosis (other than skin cancer) * Previous diagnosis of a mental health disorder * Current mental health treatment * Family history of CRC * Personal history of inflammatory bowel disease (ulcerative colitis or Crohn's disease) * Confirmed or suspected hereditary CRC syndrome, such as familial adenomatous polyposis or Lynch syndrome
References
Publications (1)
- DERIVEDEmerson B, Reiter PL, Shoben AB, Klatt M, Chakraborty S, Katz ML. A pilot randomized controlled trial of an online mindfulness-based intervention to reduce patient anxiety before a first-time screening colonoscopy. Cancer Causes Control. 2026 Mar 3;37(4):55. doi: 10.1007/s10552-026-02129-0. PMID 41774215